Melanoma
Showing NaN - NaN of 82
Melanoma Trial in Pittsburgh (administration of ipilimumab10mg/kg, administration of ipilimumab 3mg/kg + HDI)
Completed
- Melanoma
- administration of ipilimumab10mg/kg
- administration of ipilimumab 3mg/kg + HDI
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 24, 2018
Melanoma Trial in Worldwide (Tasisulam-sodium, Paclitaxel)
Terminated
- Melanoma
-
Birmingham, Alabama
- +121 more
Jun 18, 2018
Melanoma Trial in United States (GRN-1201)
Completed
- Melanoma
- GRN-1201
-
Cincinnati, Ohio
- +3 more
Jun 13, 2018
Melanoma Trial in Pittsburgh (High dose bolus interleukin-2 (HD IL2))
Terminated
- Melanoma
- High dose bolus interleukin-2 (HD IL2)
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center- Hillman Cancer Center
Mar 21, 2018
Atypical Nevi, Melanoma Trial in Pittsburgh (broccoli sprout extract - sulforaphane (BSE-SFN))
Completed
- Atypical Nevi
- Melanoma
- broccoli sprout extract - sulforaphane (BSE-SFN)
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 7, 2018
Melanoma Trial in Pittsburgh (ipilimumab)
Completed
- Melanoma
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center/University of Pittsburgh
Dec 5, 2017
Melanoma, Metastatic Melanoma Trial in United States (Vemurafenib, Bevacizumab, Cobimetinib)
Terminated
- Melanoma
- Metastatic Melanoma
- Vemurafenib
- +2 more
-
Los Angeles, California
- +13 more
Sep 22, 2017
Melanoma Trial in Pittsburgh (Nivolumab - Arm A, Nivolumab + Ipilimumab - Arm B)
Withdrawn
- Melanoma
- Nivolumab - Arm A
- Nivolumab + Ipilimumab - Arm B
-
Pittsburgh, PennsylvaniaUPMC Cancer Center Hillman Cancer Center
Sep 18, 2017
Melanoma Trial in Pittsburgh (DC Vaccine + IFN, AdVTMM2/DC Vaccination)
Completed
- Melanoma
- DC Vaccine + IFN
- AdVTMM2/DC Vaccination
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute
Aug 30, 2017
Melanoma Trial in Pittsburgh (IFNa2b, PEG- IFNa2b)
Terminated
- Melanoma
- IFNα2b
- PEG- IFNα2b
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 3, 2017
Melanoma Trial in Pittsburgh (Anti-CTLA4 mAb and HDI)
Completed
- Melanoma
- Anti-CTLA4 monoclonal antibody and HDI
-
Pittsburgh, PennsylvaniaUPCI Hillman Cancer Center
Jun 20, 2017
Prostatic Tumors, Breast Tumors, Colorectal Tumors Trial in United States (Interactive Voice Response (IVR) Reminders)
Completed
- Prostatic Neoplasms
- +4 more
- Interactive Voice Response (IVR) Reminders
-
New Haven, Connecticut
- +7 more
Jun 6, 2017
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
- Borderline Ovarian Clear Cell Tumor
- +85 more
- Laboratory Biomarker Analysis
-
Fayetteville, Arkansas
- +186 more
Oct 26, 2016
Melanoma, Cancer Trial in Canada, United States (ALVAC(2) Melanoma multi-antigen therapeutic vaccine, Intron A, Interferon alpha
Terminated
- Melanoma
- Cancer
- ALVAC(2) Melanoma multi-antigen therapeutic vaccine
- Intron A, Interferon alpha -2b
-
Tucson, Arizona
- +18 more
Apr 12, 2016
Melanoma, Breast Cancer, Head and Neck Squamous Cell Cancer Trial in Pittsburgh (Vaccinia virus (vvDD-CDSR))
Completed
- Melanoma
- +5 more
- Vaccinia virus (vvDD-CDSR)
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute
Dec 23, 2015
Cancer, Melanoma Trial in United States (Sorafenib (Nexavar, BAY43-9006), Placebo, Dacarbazine)
Completed
- Cancer
- Melanoma
- Sorafenib (Nexavar, BAY43-9006)
- +2 more
-
Tucson, Arizona
- +13 more
May 13, 2015
Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and
Terminated
- Melanoma
-
Pittsburgh, Pennsylvania
- +2 more
May 26, 2015
Melanoma Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Carboplatin/Paclitaxel, Placebo)
Completed
- Melanoma
- Sorafenib (Nexavar, BAY43-9006)
- +2 more
-
Birmingham, Alabama
- +65 more
Oct 23, 2014
Melanoma, Skin Tumors Trial in France, United States (Axitinib [AG-013736])
Completed
- Melanoma
- Skin Neoplasms
- Axitinib [AG-013736]
-
Orange, California
- +11 more
Jun 21, 2012